Thymoquinone (Novatek Pharmaceuticals)

N/A

Report date: 2026/01/22 16:42:03

Base Information

Drug NameThymoquinone (Novatek Pharmaceuticals)
Drug Alias NameTQ formulaNP-101
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionApoptosis stimulantsPolo like kinase 1 inhibitors
TargetsPolo like kinase 1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovatek Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovatek Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A